Nesting the tweets
Some items from ASCO:
@ASCO: #ASCO12 Large cohort study reveals long-term use of TZDs associated w/ increased bladder cancer risk in type 2 diabetes ow.ly/bncTf
@BeBrightPink: Research presented at #ASCO12 shows progress in the treatment of advanced #ovariancancer ow.ly/bpGoM
@CCO_Oncology: Attend our #ASCO12 symposium on metastatic colorectal cancer ? Slides are available for download: – ow.ly/bpGV4
@CrowdRecruiter: Prostate cancer update from #ASCO12 – Dendreon, Tokai Pharma, Exelixis: ow.ly/bpqH0 #mCRPC
@CR_UK: Report from #ASCO12: is immunotherapy finally coming of age? bit.ly/NiDdL0
@CR_UK: As promised earlier, here’s an in-depth look at how we helped develop vismodegib, a new drug for basal cell skin cancer bit.ly/KY5Uep
@CR_UK: Our 2nd report from #ASCO12: a new treatment for HER2-positive breast cancer? bit.ly/KVQjMk
@CR_UK: Final report from #ASCO12: global cancer cost; helping older cancer patients; and cancer care on Facebook bit.ly/MpeteD
@harriseve: Pls B honest, Doc! It’s no failure ..if a “lowly patient” has something U haven’t seen B4 @ePatientDave #ASCO12 ow.ly/bqqhj
@hmhyltonpac: TY @drdonsdizon #ASCO12 take home 3: Social Media here to stay. Know what your patients do, be involved, provide counterbal of credible info
@jodyms: Great article by @MMarchioneAP on #ASCO12: Advanced therapies being aimed at cancer bit.ly/MqE9r8 via @reflectornews
@Ideagoras: ASCO: For Oncologists or for the Street ? worldofdtcmarketing.com/asco-for-oncol… #hcsmeu #hcsmeuES #Pharma #ASCO12
@LillyPad: Global cancer cases expected to rise 75% by 2030, acc. to @TheLancet #oncology study- from #asco12 ow.ly/boLYJ
@MaverickNY: Update on prostate cancer therapies from #asco12 – are logical combos coming next? I hope so… bit.ly/KJH3fW
@MayoClinic: From #ASCO12: Mayo Clinic study finds ginseng fights fatigue in #cancerbit.ly/KqJUuD
@MayoClinic: New drug shrinks advanced basal cell carcinoma tumors – first of its kind.newsblog.mayoclinic.org/2012/06/06/new… #skincancer
@OncLive: Dr. Eric Larsen Discusses Outcomes for AYA Patients With ALL ow.ly/bqEbk#OncLiveTV #ASCO12
@PhRMA: @KateAtPhRMA highlights the increasing # of groundbreaking #cancer meds reaching the @US_FDA onphr.ma/LvnBiV #asco12
@Xconomy: Check out what Merck’s oncology chief told Xconomy about the company’s cancer pipeline leading into #ASCO12 bit.ly/KMSNeu
Some bites from the #socpharm, #epharma, #digpharm, and #pharma streams, and elsewhere:
@CeciZak: Harvard Prof Kerfoot – studying and testing vs studying alone generates greater knowledge transfer & behavior chg #spbt2012
@CadientGroup: 4 innovative campaigns that have pushed pharma social media forward.bit.ly/M14igP #socpharm
@ChristianeTrue: All my #socpharm friends, take note of No. 5: 8 Websites you need to stop building. ow.ly/bjbYB #digpharm #epharma
@ChristianeTrue: This story from @pharmalot could have come straight from TV. “Former CRO employee stole #Merck compounds” ow.ly/bnMmw #pharma #cros
@cspenn: #BWENY @jaybaer humanity is what made blogs popular and humanity is what will keep ur blog alive. Lack of it will kill ur blog.
@Digitas_Health: Sanofi’s Data Design Diabetes Challenge is a “sweet challenge,” says @ChristianeTrue in @medadnews. pharmalive.com/magazines/meda…
@fdalawblog: Rep. Markey on J&J Decision to Stop Marketing Transvaginal Mesh Medical Device – tiny.cc/vk2ffw
@GEHealthcare: Who makes the final decision when it comes to my #cancer treatment strategy? bit.ly/IEK7Gf
@LillyPad: Regardless of #ACA outcome by SCOTUS, Lilly will advocate #patient -focused reforms. #FTushc12 More here ow.ly/boGwc
@mikermyers: iPads for everyone ow.ly/bpcDm #advertising #pharma @paliosaratoga #socialmadness
@JasonBoies: 5 Ways to Tell if Pinterest is Right For Your Businesssocialmediaexaminer.com/pinterest-for-… via @smexaminer
@marciabbrem: welcome to the dream team @bobharrell from Shire Appointed VP of Marketing for @Appature bit.ly/LF9ZSI #pharma #hcmktg #hcsm #epharma
@mchiaviello: Afraid to Speak Up at the Doctor’s Office nyti.ms/KWV0FQ #epharma
@mikecapaldi: RT @CeciZak: Duncan Lennox from Qstream says that 70% of sales reps want more customized training. Are we ready? #spbt2012?
@Reuters_Health: Corrected: Do doctor-payment sunshine laws work? reut.rs/K9874b
@SermoClient: 5 Ways Social Is Helping The #Healthcare Industry bit.ly/KBeVeS via @MediaPost #socpharm #hcsmeu
@skainfo: Generation Y nurses’ constant exposure to technology distinguishes them from previous generations nursing.advanceweb.com/Features/Artic… |